Adjuvant

Scientists develop new design principles to improve cancer vaccine structure

The scientists used chemistry and nanotechnology to change the structural location of adjuvants and antigens on and within a nanoscale vaccine, greatly increasing vaccine performance. The antigen ... read more

Global Freund's Adjuvant Market [2023-2028] | The Future of Industry | A Look at the Next Decade of Market Growth

Global Freund's Adjuvant Market Status and Prospect | New Report [2023-2028] of 116Pages | Industry report provides ... read more

Transforming the way cancer vaccines are designed and made

A new way to significantly increase the potency of almost any vaccine has been developed by researchers from the International Institute for Nanotechnology (IIN) at Northwestern University. The ... read more

Novel designs of cancer vaccines developed by IIN researchers

Nature Biomedical Engineering,cancer,cancer vaccines,vaccine,IIN research,International Institute for Nanotechnology,immune system, ... read more

Researchers develop new way to increase the potency of cancer vaccines

A new way to significantly increase the potency of almost any vaccine has been developed by researchers from the International Institute for Nanotechnology (IIN) at Northwestern University. read more

Adjuvant Chemoradiotherapy Demonstrated Better Outcomes for Patients With Endometrial Cancer

Adjuvant chemoradiotherapy demonstrated improved survival and decreased recurrence rates compared to adjuvant chemotherapy in patients with state 3 endometrial cancer, according to recent study ... read more

New Design Principles To Improve Cancer Vaccines

New vaccine design principles that are based on adjusting the structural location of an adjuvant and the antigen on a nanoscale vaccine have been shown to greatly increase cancer vaccine performance. read more

FDA OKs Adjuvant Pembrolizumab for NSCLC

The approval makes pembrolizumab the only immunotherapy to be approved for NSCLC regardless of PD-L1 expression in both the adjuvant and metastatic settings, the company noted. "While there have been ... read more

Merck gets USFDA nod for KEYTRUDA as adjuvant treatment for non-small cell lung cancer

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck's anti-PD-1 therapy, as a single agent, ... read more

Ascend Capital Partners Announces Equity Investment in Allied Physicians Group and Adjuvant.Health

Ascend Capital Partners, a healthcare focused private equity partnership, today announced an equity investment in Allied Physicians Group, New York's largest independent provider of pediatric care, ... read more